ÀϺ»ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå : Medtech 360
Interventional Oncology Devices | Medtech 360 | Market Insights | Japan
»óǰÄÚµå : 1510795
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,495,000
Web Access and PDF Download (Corporate Use License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀϺ»ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½Ã¼ú °Ç¼ö´Â ¼ÒÆø Áõ°¡ÇßÁö¸¸, ÀϺ»ÀÇ °¡À̵å¶óÀÎ, ¾ö°ÝÇÑ ±â±â ½ÂÀÎ ÀýÂ÷, 2³â¿¡ ÇÑ ¹ø¾¿ ½ÃÇàµÇ´Â »óȯ »è°¨, Àüü Àα¸ °¨¼Ò, Ç×¾ÏÁ¦ °³¹ßÀÇ ÁøÀüÀ¸·Î ÀÎÇØ Àúħ½ÀÀû ÁßÀçÀû Á¾¾çÇÐ Ä¡·áÀÇ Ã¤ÅÃÀÌ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ÀϺ»ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀåÀº Ãà¼ÒµÉ °ÍÀ¸·Î ¿¹»óµÈ´Ù, ÀϺ»ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀåÀº Ãà¼ÒµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ÀϺ»ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ¿Í ºÐ¼®(2019-2033³â)À» Á¦°øÇÕ´Ï´Ù.

ÀÓ»ó °¡À̵å¶óÀÎÀº ÀϺ» ³» ÁßÀçÀû Á¾¾çÇÐ ±â±â µµÀÔ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

ÀϺ»¿¡¼­ ÁßÀçÀû Á¾¾çÇÐ ½Ã¼úÀÇ º¸±Þ¿¡ ÀÖ¾î º¸Çè±Þ¿©´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.

±àÁ¤ÀûÀÎ ÀÓ»ó µ¥ÀÌÅÍ´Â ÁßÀçÀû Á¾¾çÇÐ ±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù.

¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ±â±â ½ÂÀÎ Áö¿¬Àº ÀϺ»ÀÇ ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ½ÃÀå µ¿ÇâÀÌ º¯È­ÇÏ°í »õ·Î¿î µð¹ÙÀ̽ºÀÇ ÁøÀÔÀÌ ¿¹»óµË´Ï´Ù.

¸ñÂ÷

ÀϺ»

°³¿ä

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä º¸°í¼­ ¾÷µ¥ÀÌÆ® ÀÌ·Â

ÁßÀçÀû Á¾¾çÇÐ ±â±â ½ÃÀå

ÀýÁ¦ ±â±â ½ÃÀå

»öÀü ±â±â ½ÃÀå

¾×¼¼¼­¸® µð¹ÙÀ̽º ½ÃÀå

ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Although the interventional oncology procedure volumes are increasing marginally in Japan, the Japanese interventional oncology device market will decline due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines, stringent device approval process, biennial reimbursement cuts, declining overall population, and increasing developments in anticancer drugs.

ThisMedtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Japan from 2019 to 2033.

Clinical guidelines influence the adoption of interventional oncology devices in Japan.

Reimbursement will be an important factor in the adoption of interventional oncology procedures in Japan.

Positive clinical data will play an important role in driving the adoption of interventional oncology devices.

Stringent regulatory framework and device approval delays will impact the interventional oncology device market in Japan.

Market dynamics will change over the forecast period with anticipated entry of novel devices in this market.

Table of Contents

Japan

Abstract

Executive Summary

Key Report Updates

Interventional Oncology Device Market

Ablation Device Market

Embolization Device Market

Accessory Device Market

Appendix

Tables and Figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â